Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of S315 in Healthy Subjects
NCT04075175Phase 1Completed
- Sponsor
- MassBiologics
- Start
- Apr 2019
- Primary completion
- Oct 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in diphtheria comparing S315 with Placebo (2 arms). Primary endpoint: Number of Participants with adverse events. Started Apr 2019; status: completed.
02
Drugs
S315
03
Conditions
diphtheria
Beyond the preview
Go deeper on NCT04075175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04075175.